We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCG icon
7426
PUT
First Trust Natural Gas ETF
FCG
$648M
$293K ﹤0.01%
20,200
+9,800
+94% +$155K
PAG icon
7427
PUT
Penske Automotive Group
PAG
$14.4B
$293K ﹤0.01%
6,200
-2,400
-28% -$109K
PRK icon
7428
Park National Corp
PRK
$3.75B
$293K ﹤0.01%
+2,948
New +$286K
UVE icon
7429
CALL
Universal Insurance Holdings
UVE
$1.2B
$293K ﹤0.01%
10,500
-1,100
-9% -$32.2K
ATNX
7430
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$293K ﹤0.01%
+740
New +$205K
CLLS
7431
CALL
Cellectis
CLLS
$307M
$292K ﹤0.01%
18,700
-6,600
-26% -$118K
GSEW icon
7432
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.08B
$292K ﹤0.01%
+6,224
New +$286K
ENZ
7433
DELISTED
Enzo Biochem, Inc.
ENZ
$292K ﹤0.01%
86,668
+28,920
+50% +$102K
BLES icon
7434
Inspire Global Hope ETF
BLES
$165M
$291K ﹤0.01%
10,332
-10,476
-50% -$293K
EME icon
7435
CALL
Emcor
EME
$36.9B
$291K ﹤0.01%
3,300
-100
-3% -$8.11K
FDL icon
7436
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.99B
$291K ﹤0.01%
+9,492
New +$287K
CPE
7437
PUT
DELISTED
Callon Petroleum Company
CPE
$291K ﹤0.01%
4,420
+2,920
+195% +$211K
ENBL
7438
CALL
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$291K ﹤0.01%
21,200
+2,200
+12% +$29.8K
CNS icon
7439
Cohen & Steers
CNS
$4.36B
$290K ﹤0.01%
5,638
-70,924
-93% -$3.48M
CYTK icon
7440
CALL
Cytokinetics
CYTK
$10.3B
$290K ﹤0.01%
25,800
+3,800
+17% +$36.6K
HUBG icon
7441
CALL
HUB Group
HUBG
$2.46B
$290K ﹤0.01%
+13,800
New +$290K
ZUMZ icon
7442
PUT
Zumiez
ZUMZ
$314M
$290K ﹤0.01%
+11,100
New +$269K
ZWS icon
7443
CALL
Zurn Elkay Water Solutions
ZWS
$8.45B
$290K ﹤0.01%
19,930
-20,967
-51% -$282K
LXFR icon
7444
Luxfer Holdings
LXFR
$457M
$289K ﹤0.01%
11,782
-3,894
-25% -$94.7K
MUNI icon
7445
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
$289K ﹤0.01%
+5,260
New +$286K
VICI icon
7446
PUT
VICI Properties
VICI
$29B
$289K ﹤0.01%
13,100
-2,000
-13% -$44.7K
NGM
7447
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$289K ﹤0.01%
+19,715
New +$289K
AROC icon
7448
PUT
Archrock
AROC
$6.08B
$288K ﹤0.01%
27,200
+12,900
+90% +$127K
ERII icon
7449
CALL
Energy Recovery
ERII
$426M
$288K ﹤0.01%
27,600
+2,200
+9% +$21.6K
NRP icon
7450
Natural Resource Partners
NRP
$1.39B
$288K ﹤0.01%
8,130
-3,708
-31% -$148K

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.